Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07309757
Eligibility Criteria:
Inclusion Criteria:
* 18 years or older \> 20 weeks gestation admitted to the hospital
* Active patient-defined regular methamphetamine use for at least 1 year and any use within the last month
* Able to understand and provide informed consent
* Able to understand English
Exclusion Criteria:
These criteria will exclude women whose medications, personal traits, obstetric conditions, or diseases could confound cardiovascular risk.
* Prescribed stimulants
* Echocardiogram or EKG previously performed during current pregnancy
* Previous diagnosis of congestive heart dysfunction
* Previous diagnosis of pulmonary hypertension
* Previous myocardial infarction
* Previous diagnosis of endocarditis
* Prior cardiac intervention (repair of cardiac congenital lesion, valve replacement or repairs, percutaneous/operative treatment of arrhythmias)
* High-risk aortopathy (Marfan syndrome, bicuspid aortopathy, prior aortic dissection)
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07309757
Study Brief:
Protocol Section:
NCT07309757